ADXN · Addex Therapeutics Ltd ADR
United States · RS rating 4 · As of 2026-10-14
| Price | 2.65 USD |
|---|---|
| 1-day change | -12.0% |
| RS rating (overall / 1M / 3M / 12M) | 4 / 12 / 4 / 9 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 26 / 17 / 51 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +50.0% |
| Sales growth Q/Q | -99.2% |
| Distance from 52-week high | +75.8% |
| Market cap (USD) | $7.6M |